Latest news
ctDNA Is Becoming the New Argument Over Chemotherapy
New GALAXY data suggest ctDNA status may identify which patients with colorectal liver metastases benefit from adjuvant chemotherapy after surgery. The promise is precision. The danger is moving faster than the evidence.
Cyclospora Is Spreading. The Food Chain Still Has No Answer.
Indigenous cardiovascular inequity is not a data gap. It is a policy failure
Menopause is a cardiometabolic checkpoint. Health systems still treat it like a hormone debate
China’s Biliary-Cancer Bet Has a Global Access Problem
Alzheimer’s Trials Are Finally Blood-Gated
MS Regulators Are No Longer Reading the Same Risk
NTDs Are Now A Human-Rights Issue. Budgets Must Follow.
Europe Can Forecast Vibrio Risk. It Still Has To Act.
Cardiology has too many dashboards. The danger is forgetting the patient
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.